Novasep Process introduced Biopharmaceutical Sequential Chromatography (BioSC) sequential multi-column chromatography product, which improves throughput and stationary phase productivity for downstream processes up to four-times. BioSC enables biopharmaceutical firms to significantly improve the productivity (grams protein/liter, resin/day) of their current chromatography processes while simultaneously increasing process flow rates and dramatically decreasing water usage when compared to conventional batch column chromatography, according to the company.
BioSC reduces the number and size of current process steps by more efficiently using the working capacity of the stationary phase and full automation of the continuous process. BioSC can accommodate the higher titers produced by modern upstream cell cultures while delivering continuous processes that maximize production efficiency and minimize product delays.
www.novasep.com
